Kyowa Kirin (KYKOF) News Today $16.75 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Kura Oncology Shares Fall 14% on Plans for Cancer-Drug CollaborationNovember 20 at 8:50 PM | marketwatch.comKura Oncology, Kyowa Kirin to develop and commercialize ziftomenib in leukemiasNovember 20 at 8:50 PM | markets.businessinsider.comKura Oncology Partners With Kyowa Kirin To Develop Ziftomenib For Acute Leukemias; Stock DropsNovember 20 at 8:50 PM | markets.businessinsider.comKura Oncology to partner with Kyowa Kirin for blood cancer therapyNovember 20 at 5:52 PM | reuters.comKyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical CompanyOctober 31, 2024 | businesswire.comKyowa Kirin Announces Positive Interim Real-world Data for Mogamulizumab (Poteligeo®) in Cutaneous T-cell Lymphoma at EORTC-CLTG 2024October 8, 2024 | businesswire.comKyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic DermatitisSeptember 25, 2024 | prnewswire.comKyowa Kirin to Present New Research Spotlighting Global Efforts to Advance Science and Patient Care in X-linked Hypophosphatemia at ASBMR Annual MeetingSeptember 19, 2024 | prnewswire.comA Promising Pipeline Ready to Break out at BridgeBio Pharma (BBIO)September 8, 2024 | msn.comKyowa Kirin Co., Ltd. (KYKOF)August 30, 2024 | sg.finance.yahoo.comKyowa Kirin to end distribution of Fareston (toremefine) in the United StatesAugust 23, 2024 | prnewswire.comKyowa Kirin Co., Ltd. (KYKOY)August 21, 2024 | uk.finance.yahoo.comKyowa Kirin Non-GAAP EPS of ¥70.75, revenue of ¥232.9BAugust 3, 2024 | msn.comJapan Drugmaker Kyowa Kirin Sells China Unit for $100 MillionAugust 1, 2024 | bloomberg.comKyowa Kirin Co. Ltd.July 25, 2024 | wsj.comNQASPA30LMT:IND NASDAQ ASPA Financials Large Mid Cap TR IndexJuly 25, 2024 | seekingalpha.comKyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NCJune 10, 2024 | prnewswire.comKyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024May 8, 2024 | prnewswire.comKYKOY Kyowa Kirin Co., Ltd.April 19, 2024 | seekingalpha.comKyowa Kirin Co Ltd (KY4.SG)April 16, 2024 | finance.yahoo.comKyowa Kirin: First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary SyndromeApril 15, 2024 | finanznachrichten.deFirst Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary SyndromeApril 15, 2024 | finance.yahoo.comKyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On TherapiesApril 12, 2024 | finance.yahoo.comKyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On TherapiesApril 12, 2024 | prnewswire.comKyowa Kirin Announces Acceptance of Abstract for Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting 2024April 2, 2024 | prnewswire.comKYKOF Kyowa Kirin Co., Ltd.March 26, 2024 | seekingalpha.comBreaking Down the $4.3 Million Price Tag Kyowa Kirin’s Gene Therapy for Rare Genetic DiseaseMarch 21, 2024 | msn.comKyowa Kirin's gene therapy most expensive US drug with $4.3 million price tagMarch 20, 2024 | msn.comKyowa Kirin's gene therapy most expensive US drug with $4.3 mln price tagMarch 20, 2024 | reuters.comKyowa buyout Orchard wins FDA nod for rare disease therapyMarch 19, 2024 | msn.comPharma exec talks construction, hiring for new North Carolina plantMarch 18, 2024 | bizjournals.comHow NC city lured Japanese pharma Kyowa Kirin's $200M investmentMarch 8, 2024 | bizjournals.comKyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024March 8, 2024 | finance.yahoo.comHow a North Carolina city lured Japanese pharma's $200M investmentMarch 6, 2024 | bizjournals.comKyowa Kirin to set up a new plant in Sanford, USAFebruary 28, 2024 | msn.comRock Hill misses out on $200M project from Japanese pharmaceutical company Kyowa KirinFebruary 27, 2024 | bizjournals.comKyowa Kirin Announce Symposium, Acceptance of Abstract for Presentation at American Academy of Dermatology 2024 MeetingFebruary 14, 2024 | finance.yahoo.comKyowa Kirin Announce Symposium, Acceptance of Abstract for Presentation at American Academy of Dermatology 2024 MeetingFebruary 14, 2024 | prnewswire.comBridgeBio grants Japanese rights to Kyowa Kirin for dwarfism drugFebruary 7, 2024 | msn.comBridgeBio Pharma and Kyowa Kirin Announce Partnership with an Upfront Payment of $100 Million for an Exclusive License on Infigratinib in Skeletal Dysplasias in JapanFebruary 7, 2024 | finance.yahoo.comKyowa Kirin Announces First Patient Enrolled in the Phase 2 Clinical Trial Evaluating Tivozanib Eye Drops in Patients with Diabetic Macular EdemaFebruary 6, 2024 | finance.yahoo.comBoehringer Ingelheim, Kyowa Kirin enter license agreement to develop novel treatment for fibro-inflammatory diseasesJanuary 8, 2024 | msn.comKyowa Kirin Co LtdDecember 14, 2023 | morningstar.comKyowa Kirin Co Ltd ADR KYKOYNovember 8, 2023 | morningstar.comKyowa Kirin reports 9M resultsNovember 1, 2023 | msn.comKyowa Kirin Presents Real-World Findings at ASBMR Annual Meeting Highlighting Progressive Disease Burden of X-linked Hypophosphatemia (XLH)October 16, 2023 | finance.yahoo.comKyowa Kirin to Present New Research on X-linked Hypophosphatemia (XLH) at ASBMR Annual MeetingOctober 12, 2023 | finance.yahoo.comKyowa Kirin Announces Three Abstracts and A Symposium at the European Academy of Dermatology and Venereology Congress 2023October 11, 2023 | finance.yahoo.comKyowa Kirin to acquire Orchard Therapeutics for $478 mlnOctober 5, 2023 | reuters.comOrchard Therapeutics ADSs Soar Premarket on Takeover by Kyowa KirinOctober 5, 2023 | marketwatch.com Get Kyowa Kirin News Delivered to You Automatically Sign up to receive the latest news and ratings for KYKOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide KYKOF Media Mentions By Week KYKOF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KYKOF News Sentiment▼0.000.47▲Average Medical News Sentiment KYKOF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KYKOF Articles This Week▼40▲KYKOF Articles Average Week Get Kyowa Kirin News Delivered to You Automatically Sign up to receive the latest news and ratings for KYKOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Daiichi Sankyo News Today JCR Pharmaceuticals News Today Mayne Pharma Group News Today Ono Pharmaceutical News Today Otsuka News Today Roche News Today Sanofi News Today Virbac News Today 1933 Industries News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KYKOF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyowa Kirin Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kyowa Kirin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
